Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT04093986

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Conditions: Sickle Cell Disease, Sickle Cell Anemia

Sex: All
Healthy volunteers: No
Enrollment: 200
Sponsor: Children's Hospital Medical Center, Cincinnati

Location: Cincinnati Children's Hospital Medical Center Cincinnati Ohio

Summary

The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.

Eligibility Criteria

Inclusion Criteria: * Medical records or data available from previous clinical care prior to June 20, 2019 of pregnant females with SCD, including women who miscarried, had a still birth, or completed labor at any gestational stage, with any hydroxyurea exposure during either pregnancy and/or while breastfeeding. * Medical records or data available from previous clinical care prior to June 20, 2019 about pregnancy and breastfeeding outcomes, both for babies with hydroxyurea exposure and other babies by these same women. Exclusion Criteria: * Unavailable medical records or lack of information about hydroxyurea exposure.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT04093986). StuddyBuddy aggregates publicly available trial information.